The role of TRAF6 in regulating MAP3K7/P38/MAPK pathway in the epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy
Cellular Signalling · 2026-10 · 146 · 112670
DOI: 10.1016/j.cellsig.2026.112670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026-10. Verfasst von Zhen Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The First People's Hospital of Yunnan Province, Kunming 650032, China; The Affiliated Hospital of Kunming University of …. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, TNF Receptor-Associated Factor 6, Vitreoretinopathy, Proliferative, Retinal Pigment Epithelium. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Kunming Medical University.
Abstract (Originalsprache)
Proliferative vitreoretinopathy (PVR) is a major cause of blindness. Surgery remains the primary clinical intervention, but its outcomes are frequently unsatisfactory. A deeper understanding of PVR pathophysiology is therefore essential for developing new treatments. TRAF6 is a multifunctional intracellular adaptor protein that regulates diverse biological processes, yet its role in PVR is unknown. Here, we investigated the function of TRAF6 in PVR and its downstream mechanisms using a mouse model and ARPE-19 cells. The results demonstrated that TRAF6 expression was upregulated in the retinas of PVR model mice and in ARPE-19 cells. Knockdown of TRAF6 alleviated PVR progression in mice by suppressing inflammation and the epithelial-mesenchymal transition (EMT) of retinal pigment epithelial (RPE) cells. Conversely, TRAF6 overexpression in ARPE-19 cells exacerbated TGF-β1-induced EMT. Mechanistically, TRAF6 positively regulated MAP3K7 expression via a protein-protein interaction. Knockdown of TRAF6 inhibited P38/MAPK signaling pathway activation by reducing MAP3K7 expression. Furthermore, knockdown of TRAF6 attenuated the promoting effect of MAP3K7 overexpression on TGF-β1-induced EMT in RPE cells. In conclusion, TRAF6 knockdown protects against PVR in mice by inhibiting the MAP3K7 and p38 MAPK pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The First People's Hospital of Yunnan Province, Kunming 650032, China; The Affiliated Hospital of Kunming University of Science and Technology, Kunming 650500, China.
- The Affiliated Hospital of Kunming University of Science and Technology, Kunming 650500, China.
- Department of Ophthalmology, The First People's Hospital of Yunnan Province, Kunming 650032, China.
- Department of Ophthalmology, The First People's Hospital of Yunnan Province, Kunming 650032, China; The Affiliated Hospital of Kunming University of Science and Technology, Kunming 650500, China. Electronic address: nnh…
Förderung
- Kunming Medical University
Zitieren
APA
Chen, Z., Yang, Z., Hu, Z., Lei, M., Li, Q., Zhang, W., Chen, L., Su, Y., & Ni, N. (2026). The role of TRAF6 in regulating MAP3K7/P38/MAPK pathway in the epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy. Cellular Signalling, 146, 112670. https://doi.org/10.1016/j.cellsig.2026.112670
Vancouver
Chen Z, Yang Z, Hu Z, Lei M, Li Q, Zhang W, et al. The role of TRAF6 in regulating MAP3K7/P38/MAPK pathway in the epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy. Cellular Signalling. 2026;146:112670. doi:10.1016/j.cellsig.2026.112670
BibTeX
@article{Chen2026,
author = {Chen, Zhen and Yang, Zhengrong and Hu, Zhongyin and Lei, Mingshu and Li, Qian and Zhang, Weina and Chen, Lin and Su, Yuhan and Ni, Ninghua},
title = {The role of TRAF6 in regulating MAP3K7/P38/MAPK pathway in the epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy},
journal = {Cellular Signalling},
year = {2026},
volume = {146},
pages = {112670},
doi = {10.1016/j.cellsig.2026.112670}
}
EUVIMED